LifeScan gets the green-light from the FDA for its blood glucose monitoring system that uses Bluetooth technology to wirelessly communicate with iPhone and iPad devices.
LifeScan, has received regulatory clearance from the FDA for its OneTouch VerioSync blood glucose monitoring system, the first monitoring system to integrate with the Apple app store.
The app, called the OneTouch Reveal, is available on iPhone, iPad or iPod touch.
The system automatically sends blood glucose levels to mobile devices, displaying information in a 14-day summary with simple visual breakdowns. Patients can also share information via text or email or with their doctors or friends.